4//SEC Filing
bluebird bio, Inc. 4
Accession 0001209191-17-007053
CIK 0001293971operating
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:03 PM ET
Size
9.0 KB
Accession
0001209191-17-007053
Insider Transaction Report
Form 4
Mandell James
Director
Transactions
- Exercise/Conversion
Common Stock
2017-01-31$21.43/sh+8,000$171,440→ 9,000 total - Exercise/Conversion
Stock Option (right to buy)
2017-01-31+8,000→ 4,000 totalExercise: $21.43Exp: 2024-01-08→ Common Stock (8,000 underlying) - Sale
Common Stock
2017-01-31$75.04/sh−8,000$600,322→ 1,000 total
Footnotes (3)
- [F1]This sales reported in the Form 4 were effectd pursuant to a 10b5-1 trading plan adopted by the reporting person on December 13, 2016.
- [F2]The range in prices for the transaction reported on this line was $75.00 to $75.20. The average weighted price was $75.0402. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]This option vests ratably over three years in annual installments, commencing on January 8, 2014.
Documents
Issuer
bluebird bio, Inc.
CIK 0001293971
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001293971
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:03 PM ET
- Size
- 9.0 KB